These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31275450)

  • 61. Mast cell chymase is present in uterine cervical carcinoma and it detaches viable and growing cervical squamous carcinoma cells from substratum in vitro.
    Diaconu NC; Rummukainen J; Naukkarinen A; Mättö M; Harvima RJ; Pelkonen J; Harvima IT
    Arch Dermatol Res; 2011 Sep; 303(7):499-512. PubMed ID: 21274549
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Squamous Cell Carcinoma Biomarker Sensing on a Strontium Oxide-Modified Interdigitated Electrode Surface for the Diagnosis of Cervical Cancer.
    Wang H; Lakshmipriya T; Chen Y; Gopinath SCB
    Biomed Res Int; 2019; 2019():2807123. PubMed ID: 31080815
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.
    Markovina S; Wang S; Henke LE; Luke CJ; Pak SC; DeWees T; Pfeifer JD; Schwarz JK; Liu W; Chen S; Mutch D; Wang X; Powell MA; Siegel BA; Dehdashti F; Silverman GA; Grigsby PW
    Br J Cancer; 2018 Jan; 118(1):72-78. PubMed ID: 29112685
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer.
    Yamazaki H; Todo Y; Okamoto K; Yamashiro K; Kato H
    J Gynecol Oncol; 2015 Oct; 26(4):255-61. PubMed ID: 26197769
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pretreatment Factors Associated with Recurrence for Patients with Cervical Cancer International Federation of Gynecology and Obstetrics Stage IB1 Disease.
    Liu SC; Huang EY; Hu CF; Ou YC; ChangChien CC; Wang CJ; Tsai CC; Fu HC; Wu CH; Lin H
    Gynecol Obstet Invest; 2016; 81(4):339-45. PubMed ID: 26580917
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of pretreatment squamous cell carcinoma antigen in predicting nodal metastasis in early stage cervical cancer.
    Lin H; ChangChien CC; Huang EY; Tseng CW; Eng HL; Huang CC
    Acta Obstet Gynecol Scand; 2000 Feb; 79(2):140-4. PubMed ID: 10696963
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differences in the mechanisms of production and release of SCC-Ag and CEA from an established uterine cervical carcinoma cell line (AMCC-1).
    Yabushita H; Nakagawa Y; Sawaguchi K; Noguchi M; Ishihara M
    Asia Oceania J Obstet Gynaecol; 1988 Dec; 14(4):493-500. PubMed ID: 3240127
    [No Abstract]   [Full Text] [Related]  

  • 69. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy.
    Yoon SM; Shin KH; Kim JY; Seo SS; Park SY; Moon SH; Cho KH
    Radiat Oncol; 2010 Sep; 5():78. PubMed ID: 20840788
    [TBL] [Abstract][Full Text] [Related]  

  • 71. SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.
    van de Lande J; Davelaar EM; von Mensdorff-Pouilly S; Water TJ; Berkhof J; van Baal WM; Kenemans P; Verheijen RH
    Gynecol Oncol; 2009 Jan; 112(1):119-25. PubMed ID: 19007978
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical evaluation of serum and immunohistochemical expression of SCC and CA19-9 in radiation therapy for cervical cancer.
    Abe A; Nakano T; Morita S; Oka K
    Anticancer Res; 1999; 19(1B):829-36. PubMed ID: 10216501
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy.
    Yoon SM; Shin KH; Kim JY; Seo SS; Park SY; Kang S; Cho KH
    Int J Gynecol Cancer; 2007; 17(4):872-8. PubMed ID: 17343571
    [TBL] [Abstract][Full Text] [Related]  

  • 74. SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix.
    Strauss HG; Laban C; Lautenschläger C; Buchmann J; Schneider I; Koelbl H
    Eur J Cancer; 2002 Oct; 38(15):1987-91. PubMed ID: 12376202
    [TBL] [Abstract][Full Text] [Related]  

  • 75. PD-L1 expression in anogenital and oropharyngeal squamous cell carcinomas associated with different clinicopathological features, HPV status and prognosis: a meta-analysis.
    Qin Y; Luan J; Zhou X; Li Y
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33704390
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy.
    Hong JH; Tsai CS; Chang JT; Wang CC; Lai CH; Lee SP; Tseng CJ; Chang TC; Tang SG
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):823-30. PubMed ID: 9652844
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Squamous cell carcinoma antigen and cancer antigen 125 in southern Indian cervical cancer patients.
    Porika M; Vemunoori AK; Tippani R; Mohammad A; Bollam SR; Abbagani S
    Asian Pac J Cancer Prev; 2010; 11(6):1745-7. PubMed ID: 21338226
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tumor marker index based on preoperative SCC and CYFRA 21-1 is a significant prognostic factor for patients with resectable esophageal squamous cell carcinoma.
    Qiao Y; Chen C; Yue J; Yu Z
    Cancer Biomark; 2019; 25(3):243-250. PubMed ID: 31282406
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Factors regulating SCC antigen expression in squamous cell carcinoma of the uterine cervix.
    Maruo T; Yoshida S; Samoto T; Tateiwa Y; Peng X; Takeuchi S; Motoyama S
    Tumour Biol; 1998; 19(6):494-504. PubMed ID: 9817979
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer.
    Scambia G; Benedetti Panici P; Foti E; Amoroso M; Salerno G; Ferrandina G; Battaglia F; Greggi S; De Gaetano A; Puglia G
    J Clin Oncol; 1994 Nov; 12(11):2309-16. PubMed ID: 7964945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.